1.Progress in antitumor activity of baicalin
Bang-yan KONG ; Li-bin WEI ; Qing-long GUO
Acta Pharmaceutica Sinica 2021;56(6):1537-1543
Flavonoids baicalin is the main bioactive component extracted from
2.Studies on antibacterial activity and endotoxin neutralization of murine BPI N-terminal functional fragment(muBPI_(25) protein)in vitro
Zhe Lü ; Wei WANG ; Yiqiang FAN ; Zhenlong LIU ; Qingli KONG ; Mingjie WEN ; Jun LONG ; Chen LI ; Qing XU ; Yunqing AN
Chinese Journal of Immunology 2010;26(4):294-297,303
Objective:To establish an experimental model for intracellular antibacteria and endotoxin neutralization in vitro to detect the antibacterial and endotoxin neutralization activity of the muBPI_(25) protein.Methods: RAW264.7 cells were transfected with pcDNA3.1(+)muBPI_(36-259), and then were infected with intracellular bacterial of either G ~+/G~-to establish the experimental model of intracellalar antibacteria.The RAW264.7 cells were co-transfected with the pSecTag2B-muBPI_(36-259) and dual-luciferase reporter gene plasmids for establishment of the experimental model of endotoxin neutralization.Results:The experimental model of intracellular antibacteria confirmed that the muBPI_(25) protein could inhibit/kill Salmonella typhi.The experimental model of endotoxin neutralization indicated that the muBPI_(25) protein could neutralize endotoxin.Conelusion: We firstly demonstrate that murine BPI N-terminal functional fragment(muBPI_(25) protein)can inhibit/kill Salmonella typhi,and can neutralize, its lysating product, endotoxin.
3.Prevention and management of frequent complications after endovascular repair of infrarenal abdominal aortic aneurysm.
Qing-long KONG ; Wei GUO ; Xiao-ping LIU ; Guo-hua ZHANG ; Fa-qi LIANG ; Rong LI
Chinese Journal of Surgery 2003;41(7):495-498
OBJECTIVETo prevent and manage frequent complications after endovascular repair of infrarenal abdominal aortic aneurysm (AAA).
METHODSThe data of 71 cases of infrarenal abdominal aortic aneurysm (AAA) treated by endovascular repair were analysed retrospectively. The reasons, managements, results and prognosis of frequent complications were investigated.
RESULTSSeventy-one cases of infrarenal AAA were treated by endovascular repair with 100% success rate. There was no surgical conversion to open aneurysm repair. There were 8 cases of primary endoleak, 1 case of nervous complication and acute thrombosis. An average follow-up period was 26 +/- 5 months. Three persistent endoleaks and 4 secondary endoleaks were found during the follow-up period. The endoleak rate was 9.8% (7/71) within 1 month postoperatively and mortality rate was 1.3% (1/71). Total mortality rate was 4.2% (3/71). Two patients died from acute myocardial infarction and one from acute heart failure.
CONCLUSIONSEndovascular treatment of abdominal aortic aneurysm is technically feasible and can effectively exclude aortic aneurysms from the circulation. Endoleak is a chief complication after endovascular repair of infrarenal AAA.Additional procedures and follow up are very important. Endoleak with enlarged aneurysm should be treated actively.
Aged ; Aged, 80 and over ; Aortic Aneurysm, Abdominal ; surgery ; Blood Vessel Prosthesis Implantation ; adverse effects ; methods ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Postoperative Complications ; etiology ; prevention & control ; therapy ; Prognosis ; Retrospective Studies ; Stents ; Treatment Outcome ; Vascular Fistula ; etiology ; prevention & control ; therapy
4.Biochemical Characteristics of Liver Injury Induced by Atorvastatin Combined HRZ
Lu WANG ; Jie CHEN ; Wei-Long KONG ; Ming-Li YU
Journal of Kunming Medical University 2018;39(3):42-48
Objective To provide theoretical basis for the rational use of drugs in clinic, the biochemical characteristics of liver injury induced by Atorvastatin Combined with HRZ (Isoniazid Rifampicin and Pyrazinamide) were analyzed in animal model. Me thods Eighty 8 week old SPF SD rats with half males and females were divided into four groups: control group, atorvastatin group, HRZ group, atorvastatin+HRZ group. According to the human mouse drug dose conversion, mice were given corresponding drugs by gavage.Hepatic function index of rats (the Total bilirubin, Direct bilirubin, Indirect bilirubin, Aspartate aminotransferase, Alanine aminotransferase, Alkaline phosphatase) were detected by blood from the femoral artery and hepatic function index of rats in each group on 10 d, 20 d, 40 d.Re s ults There were significant difference in the anmmistrated group on 10, 20, 40 days with higher TBIL, DBIL, IBIL than that in control group; in the admimistrated group on Day 10, combined treatment group was higher than that in cotrol group and there were significant differences in ALT;in the process of treatmen, there was statistical difference; ALP was administered for 20 days and the 40 day, atorvastatin there was HRZ group was statistically different in groupHRZ, severe injury, combination group compared with HRZ group had statistically significant difference. Conclus ions The liver injury in the three experimental groups is mild and moderate, and the liver damage is mainly cholestasis type. The most severe hepatic injury caused by Atorvastatin Combined with HRZ is aggravated by the prolonged use of drugs.
5.Clinical characteristics,hepatic pathology and 1,4-α-glucan branching enzyme gene mutations of a patient with infantile-onset glycogen storage disease type Ⅳ
Wei REN ; Guangqing XIE ; Delong KONG ; Xiaoling LONG ; Tao ZHOU ; Simao FU
Chinese Journal of Applied Clinical Pediatrics 2018;33(20):1581-1583
6.Distribution of integrons and antimicrobial resistance in carbapenem-resistant Acinetobacter bauman-nii clinical strains
Chengchao XIAO ; Mei CAO ; Long ZHANG ; Nana KONG ; Xiaotong WANG ; Linlin XIAO ; Quhao WEI
Chinese Journal of Microbiology and Immunology 2019;39(4):277-282
Objective To investigate the distribution of integrons in clinical isolates of carbapen-em-resistant Acinetobacter baumannii and their relationships to bacterial resistance to antimicrobial agents.Methods A total of 115 carbapenem-resistant Acinetobacter baumannii strains were isolated from clinical samples of patients from January to October, 2017. Phoenix 100 automatic microbiological analyzer was used for antimicrobial sensitivity analysis. Classes 1 and 2 integrase genes and carbapenemase-encoding genes, bla IMP , blaVIM , blaKPC , blaNDM and blaOXA-23 , were screened by PCR. The variable regions of integrons were amplified by long fragment PCR. The types of promoters and gene cassette arrays of variable regions were de-termined by sequencing and overlap PCR. Relationships between integrons and antimicrobial resistance were analyzed. Results The 115 isolates of carbapenem-resistant Acinetobacter baumannii were resistant to most commonly used antimicrobial agents, but sensitive to polymyxin E. All of the isolates carried blaOXA-23 gene and none of them were positive for blaIMP , blaVIM , blaKPC or blaNDM gene. Class 1 integrase gene intI1 was de-tected in 40 isolates (34. 8% ), while class 2 integrase gene intI2 was not detected. Two gene cassette ar-rays of variable regions, aacA4-catB8-aadA1 (39 isolates) and aacC1-gacP-gacQ-aadA1a (23 isolates), were detected in intI1-positive isolates. Twenty-two isolates carried both aacA4-catB8-aadA1 and aacC1-gacP-gacQ-aadA1a. The upstream promoters of the variable regions were relatively strong promoters, PcH2 and PcS. The gene cassettes of the variable regions endowed bacteria with resistance to chloramphenicol and aminoglycoside antibiotics. The resistance rate of class 1 integron-positive isolates to compound sulfamethox-azole was higher than that of negative strains. However, their resistance rate to ampicillin/sulbactam was lower than that of negative strains. Conclusions Antimicrobial resistance in carbapenem-resistant Acineto-bacter baumannii was serious. Carbapenem resistance was associated with blaOXA-23 gene. The types of pro-moters of variable regions in class 1 integrons were all relatively strong promoters. Class 1 integrons were closely related to sulfonamides resistance.
7.Success rate and influencing factors of external cephalic version for singleton pregnancies in the third trimester
Junqing LONG ; Hongwei WEI ; Hongwei XIA ; Lin KONG ; Liang SONG ; Qinling YANG ; Yuqin QIN
Chinese Journal of Obstetrics and Gynecology 2019;54(8):516-521
Objective To investigate the factors associated with the success rate of external cephalic version (ECV) for singleton and non-cephalic presentation pregnancies in the third trimester.Methods A retrospective study of ECV among singleton and non-cephalic presentation pregnant women in 36-40 weeks of gestation at Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region from January 2016 to June 2018 was analyzed.Results (1) Totally,251 cases of 358 pregnant women who underwent ECV were successful,with a total success rate of 70.1% (251/358).The success rate of multipara was 79.1% (129/163),while 62.6% (122/195) in primipara (P<0.01).The total vaginal delivery rate was 52.2% (187/358),the vaginal delivery rate of multipara was 61.3% (100/163),while 44.6% (87/195) in primipara (P<0.01).(2) Spontaneous reversion occurred in 7.6%(19/251) of ECV successful women,the rate of reversion of multipara was 10.9% (14/129),higher than that of the primipara [4.1% (5/122);P<0.01].(3) Among the 232 pregnant women who did not reverted after successful ECV,187 cases of successful vaginal delivery,the vaginal delivery rate was 80.6% (187/232);the vaginal delivery rate of the multipara was 87.0%(100/115),which was higher than that of the primipara [74.4%(87/117);P<0.01].(4) The variables significantly associated with ECV success were parity,type of breech,whether fetal presentation was in pelvic or not (all P<0.05).The complication rate was 2.2% (8/358),among which the incidence of fetal distress,placental abruption and transient fetal heart abnormalities were 0.6% (2/358),0.3% (1/358) and 1.4% (5/358) respectively.Conclusion By close monitoring,ECV is a safe and effective procedure in selected appropriate cases,and worthy of clinical application.
8.Analysis of the relationship between antimicrobial resistance and integrons of Escherichia coli isolated from community patients with urinary tract infections
Mei CAO ; Muzhen SUN ; Long ZHANG ; Xiaotong WANG ; Nana KONG ; Linlin XIAO ; Quhao WEI
Chinese Journal of Laboratory Medicine 2020;43(4):457-462
Objective:To explore the distribution of integrons in Escherichia coli isolated from community patients with urinary tract infections and their relationship with the phylogenetic groups and antimicrobial resistance. Methods:From November 2015 to December 2018, 152 isolates of E. coli that collected without repetition from the urine samples of outpatients in nephrology of Fengxian District Central Hospital in Shanghai, were studied retrospectively. Bacterial identification and antimicrobial susceptibility analysis was carried out by Phoenix 100 automatic microbiological analyzer. Class 1, 2 integron integrase genes, variable regions of integrons and the phylogenetic groups of isolated E.coli were screened by PCR. The type of promoters and gene cassette arrays of variable regions were determined by sequencing. The relationship of intergon with the phylogenetic groups and antimicrobial resistance was also analyzed. Results:The resistance rate of 152 E. coli to ampicillin was 70.39% (107/152), and the resistance rates to other antibacterial drugs were all less than 40.00%. Among the 152 E. coli isolates, class 1 integron integrase gene intI1 was detected in 65 isolates (42.76%), 8 gene cassette arrays and 14 antimicrobial resistance gene cassettes were detected in 68 class 1 integrons. The most popular gene cassette array was dfrA17-aadA5 (51.47%, 35/68), while the variable regions of class 1 integrons were failed to detected in 12 intI1-positive isolates. Five variable region promoters were detected in 68 class 1 integrons, with the relative weak promoter PcH1 to be the most popular type (77.94%, 53/68). The gene cassette array arr- 2-cmlA5-bla OXA-10-aadA1 was also detected in this study. 65 intI1-positive isolates were mainly belonged to group B2 and D. The class 2 integron integrase gene intI2 was detected in 4 isolates (2.63%,4/152), and their variable region gene cassette arrays were all dfrA1-sat2-aadA1. Conclusions:Class 1 integrons were closely related to antimicrobial resistance in E. coli isolated from community patients with urinary tract infection. Most of the variable region promoters of class 1 integrons were relatively weak promoters. The distribution of each phylogenetic group in the intI1-positive isolates was consistent with the distribution of the overall isolates. The gene cassette array arr-2-cmlA5-bla OXA-10-aadA1 was detected in E. coli.
9.Specific inhibiting effects of Ilexonin A on von Willebrand factor-dependent platelet aggregation under high shear rate.
Min LI ; Wei-kang WU ; Liang LIU ; Fu-long LIAO ; Yukito SHINOHARA ; Shunnosuke HANDA ; Shinya GOTO
Chinese Medical Journal 2004;117(2):241-246
BACKGROUNDIlexonin A (IA), purified from the Chinese herbal medicine Maodongqing (Ilex pubescens Hook, et Arn) has been commonly used in south China to treat thrombotic disorders. In this study, we aimed to study the inhibiting effects and mechanism of IA on von Willebrand factor (vWF)-dependent high shear-induced platelet aggregation.
METHODSvWF-dependent high shear (10,800 s(-1)) induced aggregation of platelets obtained from normal donors in the presence or absence of IA was measured by a modified cone-plate viscometer and shear-induced vWF binding was measured by quantitative flow cytometry with monoclonal antibody known to bind exclusively to the C-terminal domain of vWF (LJ-C3) directly labeled with fluorescein isothiocyanate (FITC). P-selectin surface expression was also measured by a similar method with FITC conjugated anti-P-selectin monoclonal antibody (WGA1).
RESULTSShear-induced platelet aggregation was inhibited by IA in a dose-dependent manner. The extent of aggregation decreased from (78.6 +/- 4.6)% in the absence of IA to (36.5 +/- 2.1)% in the presence of IA (3.3 mmol/L) (P < 0.0001, n = 9) with a high shear rate of 10800 s(-1). vWF binding and P-selectin expression were also inhibited by IA in a dose dependent manner. The number of binding FITC-LJ-C3 molecules increased after exposure of platelet-rich plasma to a high shear rate of 10800 s(-1) for 6 minutes, but this shear-induced increased binding platelet surface vWF molecules and P-selectin expression can be decreased in the presence of IA.
CONCLUSIONvWF binding and vWF mediated platelet activation, aggregation occurring under high shear rate were inhibited by IA. IA may be a unique antithrombotic drug inhibiting the vWF-GP Ibalpha interaction, and may thus facilitate drug design targeting arterial thrombosis.
Fibrinolytic Agents ; pharmacology ; Flow Cytometry ; Humans ; In Vitro Techniques ; Organic Chemicals ; Platelet Activation ; drug effects ; Platelet Aggregation ; drug effects ; Shear Strength ; von Willebrand Factor ; physiology
10.Inhibition of CaMKII alleviates myocardial ischemia?reperfusion injury by reducing mitochondrial oxidative stress in isolated perfused rat heart.
Ling-Heng KONG ; Yu-Long CHEN ; Na SUN ; Ming WEI ; Juan-Xia ZHU ; Xing-Li SU
Journal of Southern Medical University 2018;38(2):181-186
OBJECTIVETo investigate the role of calcium/calmodulin-dependent protein kinase II (CaMKII) in myocardial ischemia-reperfusion (IR) injury in isolated perfused rat heart and explore the underlying mechanisms.
METHODSAn ischemia-reperfusion (IR) model was prepared using isolated rat hearts perfused with Krebs-Henseleit solution were randomly divided into control group, 2.5 µmol/L KN-93 group, IR (induced by ischemia for 45 min followed by reperfusion for 120 min) group and KN-93+IR group. The myocardial performance was evaluated by assessing the left ventricular pressure. Lactate dehydrogenase (LDH) activity and cTnI content in the coronary flow and the infarct size were determined to evaluate the myocardial injury. The phosphorylation of CaMKII (p-CaMKII) and PLN (p-PLN) and oxidation of CaMKII (ox--CaMKII) were measured with Western blotting. The activity of mitochondrial superoxide dismutase (SOD) and the content of malondialdehyde (MDA) were determined using ELISA.
RESULTSCompared with the control group, KN-93 treatment at 2.5 µmol/L produced no significant effects on cardiac function or performance in rat hearts without IR injury. Myocardial IR injury significantly decreased myocardial performance and mitochondrial SOD activity in the perfused hearts (P<0.01) and caused significantly increased infarct size, LDH activity, cTnI content, expressions of p-CaMKII, ox-CaMKII and p-PLN, and also increased mitochondrial MDA content (P<0.01). KN-93 treatment at 2.5 µmol/L administered before ischemia and before reperfusion markedly attenuated such changes induced by ischemia and reperfusion (P<0.01).
CONCLUSIONCaMKII participates in myocardial IR injury in isolated rat heart, and inhibiting CaMKII can alleviate myocardial injury by relieving mitochondrial oxidation stress.